Core Scientific, Inc.
Core Scientific, Inc. Fundamental Analysis
Core Scientific, Inc. (CORZQ) shows moderate financial fundamentals with a PE ratio of -1.38, profit margin of -49.06%, and ROE of 48.99%. The company generates $0.5B in annual revenue with weak year-over-year growth of 1.65%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 20.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CORZQ's fundamental strength across five key dimensions:
Efficiency Score
WeakCORZQ struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCORZQ trades at attractive valuation levels.
Growth Score
WeakCORZQ faces weak or negative growth trends.
Financial Health Score
ModerateCORZQ shows balanced financial health with some risks.
Profitability Score
ModerateCORZQ maintains healthy but balanced margins.
Key Financial Metrics
Is CORZQ Expensive or Cheap?
P/E Ratio
CORZQ trades at -1.38 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CORZQ's PEG of -0.01 indicates potential undervaluation.
Price to Book
The market values Core Scientific, Inc. at -0.57 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -4.12 times EBITDA. This is generally considered low.
How Well Does CORZQ Make Money?
Net Profit Margin
For every $100 in sales, Core Scientific, Inc. keeps $-49.06 as profit after all expenses.
Operating Margin
Core operations generate 1.78 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $48.99 in profit for every $100 of shareholder equity.
ROA
Core Scientific, Inc. generates $-34.61 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Core Scientific, Inc. produces operating cash flow of $65.72M, showing steady but balanced cash generation.
Free Cash Flow
Core Scientific, Inc. produces free cash flow of $48.57M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.13 in free cash annually.
FCF Yield
CORZQ converts 14.01% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-1.38
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.01
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.57
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.68
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.45
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.20
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.49
vs 25 benchmark
ROA
Return on assets percentage
-0.35
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How CORZQ Stacks Against Its Sector Peers
| Metric | CORZQ Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -1.38 | 35.62 | Better (Cheaper) |
| ROE | 48.99% | 1160.00% | Weak |
| Net Margin | -49.06% | -136515.00% (disorted) | Weak |
| Debt/Equity | -1.45 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 0.20 | 4.79 | Weak Liquidity |
| ROA | -34.61% | -311498.00% (disorted) | Weak |
CORZQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Core Scientific, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
230.94%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
-4154.74%
Industry Style: Growth, Innovation, High Beta
DecliningFCF CAGR
2088.79%
Industry Style: Growth, Innovation, High Beta
High Growth